Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RAN binding protein 1 pseudogene (ENSG00000231744) is a non-functional genetic sequence related to the protein-coding gene RANBP1. Unlike its parent gene, the pseudogene does not produce a functional protein and is generally not considered a therapeutic target or biomarker. Pseudogenes in general may indirectly influence cellular processes by competing for RNA-binding proteins or miRNAs, thus modulating the regulation of the parental gene at a post-transcriptional level[3]. However, there are no specific functional, disease, drug, or safety associations reported for the RAN binding protein 1 pseudogene. The canonical target with biological significance is RAN binding protein 1 (RANBP1), which plays critical roles in nucleocytoplasmic transport, regulation of the cell cycle, and mitotic stability[1][5]. In summary, this entry refers to a pseudogene and should not be used as a functional therapeutic target; structured data should reference the parental gene (RANBP1) for biomedical relevance[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAN binding protein 1 pseudogene.